On July 31, 2025, the Health Resources and Services Administration (HRSA) released long-awaited guidance establishing a 340B Rebate Model Pilot Program (Pilot Program). The announcement marks a ...

The federal drug pricing program 340B helps hospitals and clinics in Virginia and across the nation care for underserved ...

“When a program designed to deliver targeted assistance drives up system-wide costs, reform is no longer optional,” says health expert Sally Pipes. “It's necessary.” If a charity organization ...

The Department of Health and Human Services is dropping the 340B Rebate Model Pilot but could potentially restart the administrative process for the program, according to a court filing. A federal ...

It's the latest evidence of rising spending in the drug discount program as regulators attempt to tamp down on growth in 340B ...

Forbes contributors publish independent expert analyses and insights. Anthony T. Lo Sasso is Professor of Public Affairs at UW-Madison This voice experience is generated by AI. Learn more. This voice ...

The dramatic growth of a key federal drug discount program has fueled debate about whether it is helping low-income patients as intended or primarily benefiting health care providers. Subscribe to our ...

The 340B Drug Pricing Program was designed to help safety net providers serve low-income patients, but it has since ballooned into a multibillion-dollar system dominated by large health systems — with ...

The Medicaid Drug Rebate Program and the 340B Drug Pricing Program are generally understood as separate efforts to promote drug affordability—one by directly subsidizing low-income patients through ...

Long-term 340B participation is linked to stronger financial assets, with much of the program’s recent growth flowing ...

The 340B drug discount program has followed a familiar health policy trajectory. An intervention that was supposed to ease cost pressures, it instead is producing cascading unintended consequences ...